← Back to search

Uncommon Therapeutics

A Disease Focused Biotech, Building Multiple Billion Dollar Drugs

Y CombinatorWinter 2025ActiveHealthcareTherapeuticsGene TherapyCRISPRBiotechnology

What they do

Problem

Patients with severe genetic diseases like Rett Syndrome lack effective, curative treatments that meaningfully improve quality of life.

Solution

The company develops novel polytherapy-based therapeutics designed to treat and potentially cure Rett Syndrome and other genetic diseases.

Who it's for

Clinicians and healthcare providers treating patients with genetic diseases, and biopharma partners seeking new therapeutics.

Founders

Noah Auerhahn
Founder

Serial Entrepreneur Building Therapies and New Biz Models for Rare Disease

LinkedIn
Ryan Lim
Founder

Biotech entrepreneur and biomedical scientist specializing in modeling neurological disorders using stem cells, in vivo models, and computational biology to drive breakthroughs in neurological diseases

LinkedIn

Company timeline

Similar startups

Nephrogen
Curative genetic medicines for kidney diseases
Invitris
Creating new protein-based drugs at scale
Tradewind BioScience
Tradewind translates scientific insight into innovative ways of…
Adventris Pharmaceuticals
Adventris makes cancer vaccines
Pardes Biosciences
We break viruses
Ochre Bio
RNA medicines for liver diseases